Purine biosynthesis de novo in rat skeletal muscle.
Purine biosynthesis by the 'de novo' pathway was demonstrated in isolated rat extensor digitorum longus muscle with [1-14C]glycine, [3-14C]serine and sodium [14C]formate as nucleotide precursors. Evidence is presented which suggests that the source of glycine and serine for purine biosynthesis is extracellular rather than intracellular. The relative incorporation rates of the three precursors were formate greater than glycine greater than serine. Over 85% of the label from formate and glycine was recovered in the adenine nucleotides, principally ATP. Azaserine markedly inhibited purine biosynthesis from both formate and glycine. Cycloserine inhibited synthesis from serine, but not from formate. Adenine, hypoxanthine and adenosine markedly inhibited purine synthesis from sodium [14C]formate.
D000225:Adenine / Q000494:pharmacology; D000241:Adenosine / Q000494:pharmacology; D000818:Animals; D001377:Azaserine / Q000494:pharmacology; D003523:Cycloserine / Q000494:pharmacology; D005260:Female; D005561:Formates / Q000378:metabolism; D005998:Glycine / Q000378:metabolism; D019271:Hypoxanthine; D007042:Hypoxanthines / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D009132:Muscles / Q000187:drug effects / Q000378:metabolism*; D011687:Purines / Q000096:biosynthesis*; D051381:Rats; D011919:Rats, Inbred Strains; D012694:Serine / Q000378:metabolism
D005561:Formates; D007042:Hypoxanthines; D011687:Purines; C030544:formic acid; D019271:Hypoxanthine; D012694:Serine; D001377:Azaserine; D003523:Cycloserine; D000225:Adenine; D000241:Adenosine; D005998:Glycine